Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Comai

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
Cellular Signalling|January 6, 2025
Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT<sub>2A</sub> receptorEtienne Billard, Alexandre Torbey, Antonio Inserra, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 22, 2025
The Genetic Landscape of Kynurenine Predicts Neurovascular Pathology and Disrupted White Matter Integrity in Patients With Mood DisordersBeatrice Bravi, Lidia Fortanyer-Uyà, Marco Paolini, et al.
Chembiochem : a European Journal of Chemical Biology|May 15, 2026
Structural and Dynamics Insights into Melatonin Binding to MT1 ReceptorClementina Acconcia, Antonella Paladino, Francesca Scebba, et al.
Neurobiology of Disease|May 5, 2018
High frequency stimulation of the anterior vermis modulates behavioural response to chronic stress: involvement of the prefrontal cortex and dorsal raphe?Francis Rodriguez Bambico, Stefano Comai, Mustansir Diwan, et al.
Pain|August 30, 2018
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic painDanilo De Gregorio, Ryan J McLaughlin, Luca Posa, et al.
Biomedicines|June 2, 2021
Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X MouseMaria Regoni, Letizia Zanetti, Stefano Comai, et al.
Drugs in R&D|August 2, 2024
Pharmacokinetics, Tolerability, and Safety of Esmethadone in Subjects with Chronic Kidney Disease or Hepatic ImpairmentNicola Ferri, Sara De Martin, James Stuart, et al.
Scientific Reports|March 31, 2023
Substantially elevated serum glutamate and CSF GOT-1 levels associated with cerebral ischemia and poor neurological outcomes in subarachnoid hemorrhage patientsSilvia Snider, Luigi Albano, Filippo Gagliardi, et al.
Molecular Psychiatry|May 28, 2024
Letter to the Editor regarding 'Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone'Marco Pappagallo, Thomas R Kosten, Charles W Gorodetzky, et al.
BMC Medicine|January 25, 2024
Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptomsStefano Comai, Nicolas Nunez, Tobias Atkin, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Cellular Signalling|January 6, 2025
Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT<sub>2A</sub> receptorEtienne Billard, Alexandre Torbey, Antonio Inserra, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 22, 2025
The Genetic Landscape of Kynurenine Predicts Neurovascular Pathology and Disrupted White Matter Integrity in Patients With Mood DisordersBeatrice Bravi, Lidia Fortanyer-Uyà, Marco Paolini, et al.
Chembiochem : a European Journal of Chemical Biology|May 15, 2026
Structural and Dynamics Insights into Melatonin Binding to MT1 ReceptorClementina Acconcia, Antonella Paladino, Francesca Scebba, et al.
Neurobiology of Disease|May 5, 2018
High frequency stimulation of the anterior vermis modulates behavioural response to chronic stress: involvement of the prefrontal cortex and dorsal raphe?Francis Rodriguez Bambico, Stefano Comai, Mustansir Diwan, et al.
Pain|August 30, 2018
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic painDanilo De Gregorio, Ryan J McLaughlin, Luca Posa, et al.
Biomedicines|June 2, 2021
Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X MouseMaria Regoni, Letizia Zanetti, Stefano Comai, et al.
Drugs in R&D|August 2, 2024
Pharmacokinetics, Tolerability, and Safety of Esmethadone in Subjects with Chronic Kidney Disease or Hepatic ImpairmentNicola Ferri, Sara De Martin, James Stuart, et al.
Scientific Reports|March 31, 2023
Substantially elevated serum glutamate and CSF GOT-1 levels associated with cerebral ischemia and poor neurological outcomes in subarachnoid hemorrhage patientsSilvia Snider, Luigi Albano, Filippo Gagliardi, et al.
Molecular Psychiatry|May 28, 2024
Letter to the Editor regarding 'Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone'Marco Pappagallo, Thomas R Kosten, Charles W Gorodetzky, et al.
BMC Medicine|January 25, 2024
Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptomsStefano Comai, Nicolas Nunez, Tobias Atkin, et al.
Pageof 13